Drug intelligence / Profile preview

Qiangli Pipa Lu

Development stage
Unknown
Lead developer
China Resources Sanjiu Medical & Pharmaceutical
Administration
Oral
01

Overview

Qiangli Pipa Lu is a Traditional Chinese Medicine (TCM) oral liquid formulation primarily indicated for the treatment of cough associated with bronchitis. The formulation is characterized by its potent antitussive (cough-suppressant) and expectorant properties. It typically contains a combination of herbal extracts, including Eriobotryae Folium (loquat leaf), Papaveris Pericarpium (poppy husk), Cynanchi Stauntonii Rhizoma et Radix, Peucedani Radix, Mori Cortex, Platycodonis Radix, and Menthol. The inclusion of Papaveris Pericarpium provides a strong antitussive effect, likely mediated by opioid alkaloids acting on the central nervous system. The drug is developed and manufactured by companies such as Anqing Echo Biopharmaceutical (also known as Anqing Huabiao Biopharmaceutical) and is approved for marketing in China.

Brand names
Qiangli Pipa LuQiangli Pipa Syrup
Other names
强力枇杷露Qiangli Pipa Oral Liquid
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on Qiangli Pipa Lu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qiangli Pipa Lu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call